Burton P J, Smith R E, Krozowski Z S, Waddell B J
Department of Anatomy and Human Biology, University of Western Australia, Nedlands, Perth, Australia.
Biol Reprod. 1996 Nov;55(5):1023-8. doi: 10.1095/biolreprod55.5.1023.
Glucocorticoid action in several target tissues is dependent on expression of 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD), and in the placenta 11 beta-HSD is thought to regulate transfer of active glucocorticoid to the fetus. This study compared expression of the two recognized 11 beta-HSD enzymes, types 1 and 2, in the rat placenta and decidua on Days 16 and 22 of gestation (term = Day 23). According to S1 nuclease protection analysis, although mRNA for 11 beta-HSD-1 was only just detectable in the labyrinth zone on Day 16, by Day 22 this expression had increased almost 20-fold. There was also an increase (approximately 2-fold) in 11 beta-HSD-1 mRNA in the basal zone between Days 16 and 22. In Day 16 decidua, 11 beta-HSD-1 mRNA was also highly expressed, but insufficient tissue was available for analysis on Day 22. Western blot analysis showed that immunoreactive 11 beta-HSD-1 (molecular mass 34 kDa) was present in those tissues with the highest 11 beta-HSD-1 mRNA expression (Day 16 decidua and Day 22 labyrinth zone). With respect to mRNA for 11 beta-HSD-2, high expression was observed in the decidua and labyrinth zone at Day 16, but in the latter this expression then declined 90% by Day 22. In contrast, expression of mRNA for 11 beta-HSD-2 increased more than 3-fold in the basal zone over the same period. Consistent with coexpression of the two 11 beta-HSD enzymes, both 11-oxoreductase and 11 beta-dehydrogenase bioactivity were clearly evident in all tissues, and each varied with stage of gestation. Specifically, 11 beta-dehydrogenase activity in the basal zone increased from 38 +/- 2% (mean +/- SEM) on Day 16 to 56 +/- 2% on Day 22, while 11-oxoreductase activity fell from 55 +/- 3% to 43 +/- 2% over the same period. In contrast, 11 beta-dehydrogenase activity in the labyrinth zone fell with advancing pregnancy (Day 16: 63 +/- 2%; Day 22: 48 +/- 2%). Both 11-oxoreductase (58 +/- 3%) and 11 beta-dehydrogenase (38 +/- 4%) activities were also evident in decidua at Day 16. In conclusion, this study shows that expression of 11 beta-HSD-1 and -2 is zone-specific in the placenta and maternal decidua. Moreover, opposite changes in the expression of the two enzymes occur in the basal and labyrinth zones of the placenta over the last days of pregnancy, indicative of distinct regulatory mechanisms and functional significance for the enzymes in the two placental zones.
糖皮质激素在多种靶组织中的作用依赖于11β-羟基类固醇脱氢酶(11β-HSD)的表达,在胎盘中,11β-HSD被认为可调节活性糖皮质激素向胎儿的转运。本研究比较了妊娠第16天和第22天(足月为第23天)大鼠胎盘和蜕膜中两种已确认的11β-HSD酶,即1型和2型的表达情况。根据S1核酸酶保护分析,尽管11β-HSD-1的mRNA在第16天仅在迷路区勉强可检测到,但到第22天,这种表达增加了近20倍。在第16天至第22天期间,基底层的11β-HSD-1 mRNA也有所增加(约2倍)。在第16天的蜕膜中,11β-HSD-1 mRNA也高度表达,但在第22天没有足够的组织用于分析。蛋白质免疫印迹分析表明,免疫反应性11β-HSD-1(分子量34 kDa)存在于11β-HSD-1 mRNA表达最高的那些组织中(第16天的蜕膜和第22天的迷路区)。关于11β-HSD-2的mRNA,在第16天的蜕膜和迷路区观察到高表达,但在迷路区,到第22天这种表达下降了90%。相比之下,同期基底层中11β-HSD-2的mRNA表达增加了3倍多。与两种11β-HSD酶的共表达一致,11-氧化还原酶和11β-脱氢酶的生物活性在所有组织中均明显可见,且每种活性随妊娠阶段而变化。具体而言,基底层的11β-脱氢酶活性从第16天的38±2%(平均值±标准误)增加到第22天的56±2%,而同期11-氧化还原酶活性从55±3%降至43±2%。相反,迷路区的11β-脱氢酶活性随着妊娠进展而下降(第16天:63±2%;第22天:48±2%)。在第16天的蜕膜中,11-氧化还原酶(58±3%)和11β-脱氢酶(38±4%)活性也很明显。总之,本研究表明11β-HSD-1和-2在胎盘和母体蜕膜中的表达具有区域特异性。此外,在妊娠最后几天,胎盘基底层和迷路区中这两种酶的表达发生相反变化,这表明这两种胎盘区域中酶的调节机制和功能意义不同。